New approaches for imaging tumour responses to treatment (original) (raw)

• Paez, J. G. et al. EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science 304, 1497–1500 (2004).
  CAS PubMed Google Scholar
• Sotiriou, C. & Piccart, M. J. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nature Rev. Cancer 7, 545–553 (2007).
  CAS Google Scholar
• Galbraith, S. M. et al. Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. J. Clin. Oncol. 21, 2831–2842 (2003).
  CAS PubMed Google Scholar
• Therasse, P. et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl Cancer Inst. 92, 205–216 (2000).
  CAS PubMed Google Scholar
• Michaelis, L. C. & Ratain, M. J. Measuring response in a post-RECIST world: from black and white to shades of grey. Nature Rev. Cancer 6, 409–414 (2006).
  CAS Google Scholar
• Weissleder, R. & Mahmood, U. Molecular imaging. Radiology 219, 316–333 (2001). A relatively early review from a pioneer (R.W.) of the field of molecular imaging.
  CAS PubMed Google Scholar
• Weissleder, R. Scaling down imaging: molecular mapping of cancer in mice. Nature Rev. Cancer 2, 1–8 (2001).
  Google Scholar
• Boone, J. M., Velazquez, O. & Cherry, S. R. Small-animal X-ray dose from micro-CT. Mol. Imaging 3, 149–158 (2004).
  PubMed Google Scholar
• von Schulthess, G. K., Steinert, H. C. & Hany, T. F. Integrated PET/CT: Current applications and future directions. Radiology 238, 405–422 (2006).
  PubMed Google Scholar
• Gee, M. S. et al. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res. 61, 2974–2982 (2001).
  CAS PubMed Google Scholar
• Czarnota, G. J. et al. Ultrasound imaging of apoptosis: high-resolution non-invasive monitoring of programmed cell death in vitro, in situ and in vivo. Br. J. Cancer 81, 520–527 (1999).
  CAS PubMed PubMed Central Google Scholar
• Pellot-Barakat, C., Sridhar, M., Lindfors, K. K. & Insana, M. F. Ultrasonic elasticity imaging as a tool for breast cancer diagnosis and research. Curr. Med. Imaging Rev. 2, 157–164 (2006).
  Google Scholar
• Sinkus, R. et al. High-resolution tensor MR elastography for breast tumour detection. Phys. Med. Biol. 45, 1649–1664 (2000).
  CAS PubMed Google Scholar
• Kaufmann, B. A. & Lindner, J. R. Molecular imaging with targeted contrast ultrasound. Curr. Opin. Biotechnol. 18, 11–16 (2007).
  CAS PubMed Google Scholar
• Johnson, G. A., Cofer, G., Gewalt, S. L. & Hedlund, L. W. Morphologic phenotyping with MR microscopy: The visible mouse. Radiology 222, 789–793 (2002).
  PubMed Google Scholar
• Artemov, D., Mori, N., Ravi, R. & Bhujwalla, Z. M. Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res. 63, 2723–2727 (2003).
  CAS PubMed Google Scholar
• Sipkins, D. A. et al. Detection of tumour angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging. Nature Med. 4, 623–626 (1998). A relatively early and much cited example of receptor imaging using MRI. A forerunner of later attempts to image angiogenesis using MRI.
  CAS PubMed Google Scholar
• Winter, P. M. et al. Molecular imaging of angiogenesis in nascent vx-2 rabbit tumors using a novel αvβ3-targeted nanoparticle and 1.5 Tesla magnetic resonance imaging. Cancer Res. 63, 5838–5843 (2003).
  CAS PubMed Google Scholar
• Zhao, M., Beauregard, D. A., Loizou, L., Davletov, B. & Brindle, K. M. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nature Med. 7, 1241–1244 (2001).
  CAS PubMed Google Scholar
• Schellenberger, E. A. et al. Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Mol. Imaging 1, 102–107 (2002).
  CAS PubMed Google Scholar
• Jung, H. I., Kettunen, M. I., Davletov, B. & Brindle, K. M. Detection of apoptosis using the C2A domain of synaptotagmin, I. Bioconjug. Chem. 15, 983–987 (2004).
  CAS PubMed Google Scholar
• Bulte, J. W. M. & Kraitchman, D. L. Monitoring cell therapy using iron oxide MR contrast agents. Curr. Pharm. Biotech. 5, 567–584 (2004).
  CAS Google Scholar
• Aime, S., Barge, A., Cabella, C., Crich, S. G. & Gianolio, E. Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates. Curr. Pharm. Biotech. 5, 509–518 (2004).
  CAS Google Scholar
• Dodd, S. J. et al. Detection of single mammalian cells by high resolution magnetic resonance imaging. Biophys. J. 76, 103–109 (1999).
  CAS PubMed PubMed Central Google Scholar
• Franklin, R. J. M. et al. Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brain. NeuroReport 10, 1–5 (1999).
  Google Scholar
• Bulte, J. W. M. et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination. Proc. Natl Acad. Sci. USA 96, 15256–15261 (1999).
  CAS PubMed PubMed Central Google Scholar
• Kircher, M. F. et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res. 63, 6838–6846 (2003).
  CAS PubMed Google Scholar
• Hu, D.-E., Kettunen, M. I. & Brindle, K. M. Monitoring T-lymphocyte trafficking in tumors undergoing immune rejection. Magn. Reson. Med. 54, 1473–1479 (2005).
  CAS PubMed Google Scholar
• de Vries, I. J. M. et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nature Biotech. 23, 1407–1413 (2005).
  CAS Google Scholar
• Ahrens, E. T., Flores, R., Xu, H. Y. & Morel, P. A. In vivo imaging platform for tracking immunotherapeutic cells. Nature Biotech. 23, 983–987 (2005).
  CAS Google Scholar
• Preul, M. C. et al. Accurate, non-invasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nature Med. 2, 232–325 (1996). An early example of the use of MRS and pattern-recognition techniques to classify brain tumours.
  Google Scholar
• Tate, A. R. et al. Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR Biomed. 19, 411–434 (2006).
  CAS PubMed Google Scholar
• Gillies, R. J. & Morse, D. L. In vivo magnetic resonance spectroscopy in cancer. Ann. Rev. Biomed. Bioeng. 7, 287–326 (2005).
  CAS Google Scholar
• Jeffrey, F. M. H., Rajagopal, A., Malloy, C. R. & Sherry, A. D. 13C NMR: A simple yet comprehensive method for analysis of intermediary metabolism. Trends Biochem. Sci. 16, 5–10 (1991). A readily accessible review from a group that pioneered 13 C NMR and 13 C-labeling techniques, particularly with multiply labeled compounds, for interrogating cellular metabolism.
  CAS PubMed Google Scholar
• Golman, K., Ardenkjær-Larsen, J. H., Petersson, J. S., Månsson, S. & Leunbach, I. Molecular imaging with endogenous substances. Proc. Natl Acad. Sci. USA 100, 10435–10439 (2003).
  CAS PubMed PubMed Central Google Scholar
• Golman, K., in ' t Zandt, R. & Thaning, M. Real-time metabolic imaging. Proc. Natl Acad. Sci. USA 103, 11270–11275 (2006).
  CAS PubMed PubMed Central Google Scholar
• Golman, K., Zandt, R. I., Lerche, M., Pehrson, R. & Ardenkjaer-Larsen, J. H. Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Res. 66, 10855–10860 (2006).
  CAS PubMed Google Scholar
• Golman, K. & Petersson, J. S. Metabolic imaging and other applications of hyperpolarized 13C. Acad. Radiol. 13, 932–942 (2006).
  PubMed Google Scholar
• Gambhir, S. S. Molecular imaging of cancer with positron emisson tomography. Nature Rev. Cancer 2, 683–693 (2002).
  CAS Google Scholar
• Folli, S. et al. Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. Cancer Res. 54, 2643–2649 (1994).
  CAS PubMed Google Scholar
• Becker, A. et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nature Biotech. 19, 327–331 (2001). A good example of using a targeted optical agent for tumour detection.
  CAS Google Scholar
• Kelly, K., Alencar, H., Funovics, M., Mahmood, U. & Weissleder, R. Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res. 64, 6247–6251 (2004).
  CAS PubMed Google Scholar
• Weissleder, R., Tung, C.-H., Mahmood, U. & Bogdanov, A. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nature Biotech. 17, 375–378 (1999). A classic and much cited example of a molecular beacon for measuring tumour-associated protease activity.
  CAS Google Scholar
• Alencar, H. et al. Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection—study in mice. Radiology 244, 232–238 (2007).
  PubMed Google Scholar
• Ntziachristos, V., Yodh, A. G., Schnall, M. & Chance, B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc. Natl Acad. Sci. USA 97, 2767–2772 (2000). A paper that describes NIR imaging in the human.
  CAS PubMed PubMed Central Google Scholar
• Inoue, H., Kudo, S.-e. & Shiokawa, A. Technology Insight: laser scanning confocal microscopy and endocytoscopy for cellular observation of the gastrointestinal tract. Nature Clin. Prac. Gasteroenterol. Hepatol. 2, 31–37 (2005).
  Google Scholar
• Yun, S. H. et al. Comprehensive volumetric optical microscopy in vivo. Nature Med. 12, 1429–1433 (2006).
  CAS PubMed Google Scholar
• Boppart, S. A., Oldenburg, A. L., Xu, C. Y. & Marks, D. L. Optical probes and techniques for molecular contrast enhancement in coherence imaging. J. Biomed. Optics 10, 041208 (2005).
  Google Scholar
• Kendall, C. et al. Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett's oesophagus. J. Pathol. 200, 602–609 (2003).
  PubMed Google Scholar
• Short, K. W., Carpenter, S., Freyer, J. P. & Mourant, J. R. Raman spectroscopy detects biochemical changes due to proliferation in mammalian cell cultures. Biophys. J. 88, 4274–4288 (2005).
  CAS PubMed PubMed Central Google Scholar
• Massoud, T. F. & Gambhir, S. S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 17, 545–580 (2003). An encyclopaedic review from another pioneer (S.S.G.) in the field of molecular imaging.
  CAS PubMed Google Scholar
• Bhaumik, S. & Gambhir, S. S. Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc. Natl Acad. Sci. USA 99, 377–382 (2002).
  CAS PubMed Google Scholar
• Hardy, J. et al. Bioluminescence imaging of lymphocyte trafficking in vivo. Exp. Hematol. 29, 1353–1360 (2001).
  CAS PubMed Google Scholar
• Sweeney, T. J. et al. Visualizing the kinetics of tumor-cell clearance in living animals. Proc. Natl Acad. Sci. USA 96, 12044–12049 (1999).
  CAS PubMed PubMed Central Google Scholar
• Vooijs, M., Jonkers, J., Lyons, S. & Berns, A. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res. 62, 1862–1867 (2002). An elegant example of how to detect early-stage tumours in a mouse model using bioluminescent imaging.
  CAS PubMed Google Scholar
• Gatenby, R. A. & Gillies, R. J. Why do cancers have high aerobic glycolysis? Nature Rev. Cancer 4, 891–899 (2004).
  CAS Google Scholar
• Brown, R., Leung, J. & Fisher, S. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: correlation between Glut-1 expression and FDG uptake. J. Nucl. Med. 37, 1042–1047 (1996).
  CAS PubMed Google Scholar
• Smith, T. A. D. The rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporation. Nucl. Med. Biol. 28, 1–4 (2001).
  CAS PubMed Google Scholar
• Juweid, M. E. & Cheson, B. D. Positron-emission tomography and assessment of cancer therapy. N. Engl. J. Med. 354, 496–507 (2006).
  CAS PubMed Google Scholar
• Weber, W. A et al. Positron emission tomography in non-small-cell lung cancer: Prediction of response to chemotherapy by quantitative assessment of glucose use. J. Clin. Oncol. 21, 2651–2657 (2003).
  CAS PubMed Google Scholar
• Weber, W. A. et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J. Clin. Oncol. 19, 3058–3065 (2001).
  CAS PubMed Google Scholar
• Spaepen, K. et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG PET a valid alternative to conventional diagnostic methods? J. Clin. Oncol. 19, 414–419 (2001).
  CAS PubMed Google Scholar
• Schelling, M. et al. Positron emission tomography using [18F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J. Clin. Oncol. 18, 1689–1695 (2000).
  CAS PubMed Google Scholar
• Avril, N. et al. Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer. J. Clin. Oncol. 23, 7445–7453 (2005).
  PubMed Google Scholar
• Stroobants, S. et al. 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur. J. Cancer 39, 2012–2020 (2003). A well-known example of how FDG PET can detect response before changes in tumour size.
  CAS PubMed Google Scholar
• Cullinane, C. et al. An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development. Cancer Res. 65, 9633–9636 (2005).
  CAS PubMed Google Scholar
• Su, H. et al. Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clin. Cancer Res. 12, 5659–5667 (2006).
  CAS PubMed Google Scholar
• Weber, W. A. Positron emission tomography as an imaging biomarker. J. Clin. Oncol. 24, 3282–3292 (2006). A recent and well-written review of the role of PET in oncology.
  CAS PubMed Google Scholar
• Poptani, H. et al. Detecting early response to cyclophosphamide treatment of RIF-1 tumors using selective multiple quantum spectroscopy (SelMQC) and dynamic contrast enhanced imaging. NMR Biomed. 16, 102–111 (2003).
  CAS PubMed Google Scholar
• Ardenkjaer-Larsen, J. H. et al. Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR. Proc. Natl Acad. Sci. USA 100, 10158–10163 (2003). The first description of dissolution dynamic nuclear polarization, a technique that could have an enormous effect on imaging tissue function using magnetic resonance.
  CAS PubMed PubMed Central Google Scholar
• Day, S. E. et al. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nature Med. 13, 1382–1387 (2007). The first example of the use of hyperpolarized magnetic resonance spectroscopic imaging to detect the response of tumours to therapy.
  CAS PubMed Google Scholar
• Shields, A. F. et al. Carbon-11-thymidine and FDG to measure therapy response. J. Nucl. Med. 39, 1757–1762 (1998).
  CAS PubMed Google Scholar
• Wells, P. et al. Assessment of proliferation in vivo using 2-[11C]thymidine positron emission tomography in advanced intra-abdominal malignancies. Cancer Res. 62, 5698–5702 (2002).
  CAS PubMed Google Scholar
• Shields, A. F. et al. Imaging proliferation in vivo with [18F]FLT and positron emission tomography. Nature Med. 11, 1334–1336 (1998). The first description of FLT as a PET probe of cell proliferation.
  Google Scholar
• Vesselle, H. et al. In vivo validation of 3′-deoxy-3′-[18F]fluorothymidine ([18F]FLT) as a proliferation imaging tracer in humans: correlation of [18F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. Clin. Cancer Res. 8, 3315–3323 (2002).
  CAS PubMed Google Scholar
• Pio, B. S. et al. Usefulness of 3′-[18F]fluoro-3′-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy. Mol. Imaging Biol. 8, 36–42 (2006).
  PubMed Google Scholar
• an Waarde, A., Been, L. B., Ishiwata, K., Dierckx, R. A. & Elsinga, P. H. Early response of sigma-receptor ligands and metabolic PET tracers to 3 forms of chemotherapy: an in vitro study in glioma cells. J. Nucl. Med. 47, 1538–1545 (2006).
  Google Scholar
• Jager, P. L. et al. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J. Nucl. Med. 42, 432–445 (2001).
  CAS PubMed Google Scholar
• Nuutinen, J., Jyrkkiö, S., Lehikoinen, P., Lindholm, P. & Minn, H. Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography. Radiother. Oncol. 52, 225–232 (1999).
  CAS PubMed Google Scholar
• Wieder, H. et al. PET imaging with [11C]methyl-L-methionine for therapy monitoring in patients with rectal cancer. Eur. J. Nuc. Med. Mol. Imaging 29, 789–796 (2002).
  CAS Google Scholar
• Ishimori, T. et al. 18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy. Ann. Nucl. Med. 18, 669–674 (2004).
  PubMed Google Scholar
• Galldiks, N. et al. Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. Eur. J. Nuc. Med. Mol. Imaging 33, 516–524 (2006).
  CAS Google Scholar
• Nuutinen, J. et al. Radiotherapy treatment planning and long-term follow-up with [11C]methionine pet in patients with low-grade astrocytoma. Int. J. Radiat. Oncol. Biol. Phys. 48, 43–52 (2000).
  CAS PubMed Google Scholar
• Yoshimoto, M. et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: Acetate metabolism in tumor cells. Nucl. Med. Biol. 28, 117–122 (2001).
  CAS PubMed Google Scholar
• Jana, S. & Blaufox, M. D. Nuclear medicine studies of the prostate, testes, and bladder. Semin. Nucl. Med. 36, 51–72 (2006).
  PubMed Google Scholar
• Oyama, N. et al. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J. Nucl. Med. 44, 549–555 (2003).
  CAS PubMed Google Scholar
• Glunde, K., Jacobs, M. A. & Bhujwalla, Z. M. Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev. Mol. Diag. 6, 821–829 (2006). A recent review of the role of choline metabolism in tumour cell proliferation and different ways of imaging this from a group that has been very active in this field.
  CAS Google Scholar
• Meisamy, S. et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with _in vivo_1H MR spectroscopy — A pilot study. Radiology 233, 424–431 (2004).
  PubMed Google Scholar
• Kurhanewicz, J., Vigneron, D. B. & Nelson, S. J. Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia 2, 166–189 (2000).
  CAS PubMed PubMed Central Google Scholar
• DeGrado, T. R. et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: Initial findings in prostate cancer. Cancer Res. 61, 110–117 (2001).
  CAS PubMed Google Scholar
• Liu, D. et al. Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycin. Br. J. Cancer 87, 783–789 (2002).
  CAS PubMed PubMed Central Google Scholar
• Chung, Y. L. et al. Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino, 17-demethoxygeldanamycin (17AAG) in human colon cancer models. J. Natl Cancer Inst. 95, 1624–1633 (2003). MRS as a tool for detecting drug action.
  CAS PubMed Google Scholar
• Anthony, M. L., Zhao, M. & Brindle, K. M. Inhibition of phosphatidylcholine biosynthesis following induction of apoptosis in HL-60 cells. J. Biol. Chem. 274, 19686–19692 (1999).
  CAS PubMed Google Scholar
• Dubray, B. et al. In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas. Radiother. Oncol. 46, 185–191 (1998).
  CAS PubMed Google Scholar
• Chang, J. et al. Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma. Cancer 89, 2145–2152 (2000).
  CAS PubMed Google Scholar
• Ellis, P. A. et al. Preoperative chemotherapy induces apoptosis in early breast cancer. Lancet 349, 849 (1997).
  CAS PubMed Google Scholar
• Meyn, R. E. et al. Heterogeneity in apoptosis development in irradiated murine tumours of different histologies. Int. J. Radiat. Biol. 64, 583–591 (1993).
  CAS PubMed Google Scholar
• Kettunen, M. I. & Brindle, K. M. Apoptosis detection using magnetic resonance imaging and spectroscopy. Prog. Nucl. Mag. Reson. Spectrosc. 47, 175–185. (2005).
  CAS Google Scholar
• Moffat, B. A. et al. Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc. Natl Acad. Sci. USA 102, 5524–5529 (2005). A clinically applicable and label-free MRI method for detecting early tumour responses to treatment.
  CAS PubMed PubMed Central Google Scholar
• Corsten, M. F., Hofstra, L., Narula, J. & Reutelingsperger, C. P. Counting heads in the war against cancer: defining the role of annexin A5 imaging in cancer treatment and surveillance. Cancer Res. 66, 1255–1260 (2006). A recent review describing the use of labelled annexin to detect cell death.
  CAS PubMed Google Scholar
• Belhocine, T. et al. Increased uptake of the apoptosis-imaging agent 99mTc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin. Cancer Res. 8, 2766–2774 (2002).
  CAS PubMed Google Scholar
• Cauchon, N. et al. PET imaging of apoptosis with 64Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V. Eur. J. Nucl. Med. Mol. Imaging 34, 247–258 (2007).
  CAS PubMed Google Scholar
• Neves, A. A. et al. A paramagnetic nanoprobe to detect tumor cell death using magnetic resonance imaging. Nano Lett. 7, 1419–1423 (2007).
  CAS PubMed Google Scholar
• Petrovsky, A., Schellenberger, E., Josephson, L., Weissleder, R. & Bogdanov, A. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res. 63, 1936–1942 (2003).
  CAS PubMed Google Scholar
• Boersma, H. H. et al. Past, present, and future of annexin A5: from protein discovery to clinical applications. J. Nucl. Med. 46, 2035–2050 (2005).
  CAS PubMed Google Scholar
• Van Den Bossche, B. & de Wiele, C. V. Receptor imaging in oncology by means of nuclear medicine: Current status. J. Clin. Oncol. 22, 3593–3607 (2004).
  CAS PubMed Google Scholar
• Teunissen, J. J. M., Kwekkeboom, D. J. & Krenning, E. P. Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatostatin analogs. Trends Endocrinol. Metab. 17, 19–25 (2006).
  CAS PubMed Google Scholar
• Linden, H. M. et al. Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. J. Clin. Oncol. 24, 2793–2799 (2006).
  CAS PubMed Google Scholar
• Dehdashti, F. et al. Positron tomographic assessment of androgen receptors in prostatic carcinoma. Eur. J. Nuc. Med. Mol. Imaging 32, 344–350 (2005).
  Google Scholar
• Orlova, A. et al. Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res. 66, 4339–4348 (2006).
  CAS PubMed Google Scholar
• Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249–257 (2000).
  CAS PubMed Google Scholar
• Tozer, G. M., Kanthou, C. & Baguley, B. C. Disrupting tumour blood vessels. Nature Rev. Cancer 5, 423–435 (2005).
  CAS Google Scholar
• Folkman, J. Angiogenesis. Annu. Rev. Med. 57, 1–18 (2006).
  CAS PubMed Google Scholar
• Miller, J. C., Pien, H. H., Sahani, D., Sorensen, A. G. & Thrall, J. H. Imaging angiogenesis: Applications and potential for drug development. J. Natl Cancer Inst. 97, 172–187 (2005).
  CAS PubMed Google Scholar
• Leach, M. O. et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br. J. Cancer 92, 1599–1610 (2005). A discussion of the methods for assessing response to anti-angiogenic and anti-vascular treatments using dynamic contrast agent-enhanced MRI.
  CAS PubMed PubMed Central Google Scholar
• McDonald, D. M. & Choyke, P. L. Imaging of angiogenesis: from microscope to clinic. Nature Med. 9, 713–725 (2003).
  CAS PubMed Google Scholar
• Morgan, B. et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: Results from two phase I studies. J. Clin. Oncol. 21, 3955–3964 (2003).
  CAS PubMed Google Scholar
• Barrett, T., Kobayashi, H., Brechbiel, M. & Choyke, P. L. Macromolecular MRI contrast agents for imaging tumor angiogenesis. Eur. J. Radiol. 60, 353–366 (2006).
  PubMed Google Scholar
• Abramovitch, R., Dafni, H., Smouha, E., Benjamin, L. E. & Neeman, M. In vivo prediction of vascular susceptibility to vascular endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice. Cancer Res. 59, 5012–5016 (1999).
  CAS PubMed Google Scholar
• Beauregard, D. A., Hill, S. A., Chaplin, D. J. & Brindle, K. M. The susceptibility of tumors to the anti-vascular drug combretastatin A4 phosphate correlates with vascular permeability. Cancer Res. 61, 6811–6815 (2001).
  CAS PubMed Google Scholar
• Haubner, R. et al. Noninvasive visualization of the activated avb3 integrin in cancer patients by positron emission tomography and [18F]galacto-RGD. PLOS Med. 2, 244–252 (2005).
  CAS Google Scholar
• Ljungkvist, A. S. E., Bussink, J., Kaanders, J. H. A. M. & Van der Kogel, A. J. Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers. Radiat. Res. 167, 127–145 (2007).
  CAS PubMed Google Scholar
• Eschmann, S. M. et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J. Nucl. Med. 46, 253–260 (2005).
  PubMed Google Scholar
• Gagel, B. et al. [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study. BMC Cancer 6, 51 (2006).
  PubMed PubMed Central Google Scholar
• Czernin, J., Weber, W. A. & Herschman, H. R. Molecular imaging in the development of cancer therapeutics. Annu. Rev. Med. 57, 99–118 (2006).
  CAS PubMed Google Scholar
• Smith, T. A. D., Sharma, R. I., Thompson, A. M. & Paulin, F. E. M. Tumor 18F-FDG incorporation is enhanced by attenuation of p53 function in breast cancer cells in vitro. J. Nucl. Med. 47, 1525–1530 (2006).
  CAS PubMed Google Scholar
• Ho, C.-l., Chen, S., Yeung, D. W. C. & Cheng, T. K. C. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. J. Nucl. Med. 48, 902–909 (2007).
  CAS PubMed Google Scholar
• Segal, E. et al. Decoding global gene expression programs in liver cancer by noninvasive imaging. Nature Biotech. 25, 675–680 (2007). A fascinating study correlating defined imaging traits in CT scans with gene-expression profiles, raising the possibility that gene-expression programmes might be inferred from imaging studies.
  CAS Google Scholar
• Zhang, Y. Y., Brady, M. & Smith, S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging 20, 45–57 (2001).
  CAS PubMed Google Scholar
• Frese, K. K. & Tuveson, D. A. Maximizing mouse cancer models. Nature Rev. Cancer 7, 654–658 (2007). Realistic animal models of disease should assist the development of novel clinical imaging methods. This review describes the current state-of-the-art for these models.
  Google Scholar
• Trepel, M., Arap, W. & Pasqualini, R. In vivo phage display and vascular heterogeneity: implications for targeted medicine. Curr. Opin. Chem. Biol. 6, 399–404 (2002).
  CAS PubMed Google Scholar
• Haubner, R. & Wester, H. R. Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies. Curr. Pharm. Design 10, 1439–1455 (2004).
  CAS Google Scholar
• Aina, O. H. et al. From combinatorial chemistry to cancer-targeting peptides. Mol. Pharm. 4, 631–651 (2007).
  CAS PubMed Google Scholar
• Serganova, I. & Blasberg, R. Reporter gene imaging: potential impact on therapy. Nucl. Med. Biol. 32, 763–780 (2005).
  CAS PubMed Google Scholar
• Tjuvajev, J. G. et al. Imaging adenoviral-mediated Herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res. 59, 5186–5193 (1999). An early example of a radionuclide-based gene reporter.
  CAS PubMed Google Scholar
• Genove, G., DeMarco, U., Xu, H. Y., Goins, W. F. & Ahrens, E. T. A new transgene reporter for in vivo magnetic resonance imaging. Nature Med. 11, 450–454 (2005).
  CAS PubMed Google Scholar
• Doubrovin, M. et al. Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc. Natl Acad. Sci. USA 98, 9300–9305 (2001). An early example of the way a PET-based gene reporter can be used to image specific aspects of cell biology in vivo.
  CAS PubMed PubMed Central Google Scholar
• Zhou, J. Y. & van Zijl, P. C. M. Chemical exchange saturation transfer imaging and spectroscopy. Prog. Nucl. Mag. Res. Sp. 48, 109–136 (2006).
  CAS Google Scholar
• Aime, S. et al. Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations. J. Mag. Res. Imaging 16, 394–406 (2002).
  Google Scholar
• Schröder, L., Lowery, T. J., Hilty, C., Wemmer, D. E. & Pines, A. Molecular imaging using a targeted magnetic resonance hyperpolarized biosensor. Science 314, 446–449 (2006).
  PubMed Google Scholar
• Beekman, F. & van der Have, F. The pinhole: gateway to ultra-high-resolution three-dimensional radionuclide imaging. Eur. J. Nuc. Med. Mol. Imaging 34, 151–161 (2007).
  Google Scholar
• Salerno, M. et al. Hyperpolarized noble gas MR imaging of the lung: Potential clinical applications. Eur. J. Radiol. 40, 33–44 (2001).
  CAS PubMed Google Scholar